How aging influences cancer progression and treatment response
AGING AS A SELECTIVE PRESSURE THAT DRIVES TUMOR PROGRESSION
This study is looking at how getting older affects cancer and its treatment, especially for people aged 65 and up, to find better ways to help older adults fight cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-11015947 on NIH RePORTER |
What this research studies
This research investigates the relationship between aging and cancer, focusing on how age affects cancer progression and the effectiveness of anti-cancer therapies. It aims to understand the biological changes that occur in older patients, particularly those aged 65 and above, and how these changes influence tumor behavior and treatment outcomes. By analyzing human serum samples, the research seeks to uncover the metabolic deregulations associated with aging that may contribute to cancer development and progression. The goal is to provide insights that could lead to more effective cancer treatments tailored for older adults.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 65 and older who are diagnosed with cancer.
Not a fit: Patients under the age of 65 or those without a cancer diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatments specifically designed for older patients, enhancing their chances of recovery and quality of life.
How similar studies have performed: Other research has indicated that understanding the role of aging in cancer can lead to significant advancements in treatment strategies, suggesting that this approach has potential for success.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Da Silva Gomes, Ana — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Da Silva Gomes, Ana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.